XAF-1, a diagnostic marker for interferon responsiveness in multiple sclerosis

Details for Australian Patent Application No. 2007222852 (hide)

Owner Aegera Therapeutics Inc.

Inventors Hebb, Andrea; Bhan, Virender; Moore, Craig; Holcik, Martin; Korneluk, Robert G.; Robertson, George

Agent Spruson & Ferguson

Pub. Number AU-A-2007222852

PCT Pub. Number WO2007/101341

Priority 60/778,907 06.03.06 US

Filing date 5 March 2007

Wipo publication date 13 September 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/101341 Priority application(s): WO2007/101341

11 December 2008 Alteration of Name

  The name of the applicant has been altered to Aegera Therapeutics, Inc.; The Children's Hospital of Eastern Ontario

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222860-Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis

2007222843-Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer